Encepur

04/01/2004 - "Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule."
03/04/2009 - "Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children."
03/04/2009 - "Two paediatric tick-borne encephalitis vaccines, Encepur Children and FSME-IMMUN Junior, are used widely in Europe. "
02/05/2009 - "Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults."
06/12/2006 - "A prospective, randomised, multicentre, single-blind phase 3 study was performed to assess the safety of a vaccination schedule consisting of two vaccinations (21-35 days apart) with the tick-borne encephalitis (TBE) vaccine FSME-IMMUN "adults" (five consecutive lots) in comparison to another licensed TBE vaccine (Encepur), with polygeline) (two lots) in healthy volunteers (n=3966) aged 16-65 years. "

05/11/2009 - "During the first year and 2 years after the primary three vaccinations the antibodies to the Far Eastern subtype tick-borne encephalitis virus strain P-73 were detected by neutralization test after immunization with FSME-Immune Inject vaccine (Baxter Vaccine AG, Austria) in 88.2% and 78.1% vaccinated persons, respectively; with Encepur((R)) Adult vaccine (Novartis Vaccines, Germany), in 100% and 100%; with the vaccine of the Chumakov Institute of Poliomyelitis and Viral Encephalitides RAMSci (Russia), in 100% and 94.1%; with EnceVir vaccine (Russia), in 88.2% and 83.9%; and after combined vaccination, in 100% and 92.7%. "

06/01/2007 - "[Vaccination with Encepur of children using the rapid scheme produces stable and long-term prevention of tick-borne meningoencephalitis]."